Found: 94
Select item for more details and to access through your institution.
Mendelian randomization combined with multi-omics explores the relationship between heart failure and cancer.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 10, p. 2928, doi. 10.7150/jca.94142
- By:
- Publication type:
- Article
Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 6, p. 1, doi. 10.1002/cam4.6991
- By:
- Publication type:
- Article
Visualisation of CP-violation effects in decay-time-dependent analyses of multibody B-meson decays.
- Published in:
- European Physical Journal C -- Particles & Fields, 2024, v. 84, n. 3, p. 1, doi. 10.1140/epjc/s10052-024-12615-x
- By:
- Publication type:
- Article
Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2023 ASH annual meeting.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, p. 1, doi. 10.1186/s40164-024-00486-7
- By:
- Publication type:
- Article
Tumor-derived exosomes induce initial activation by exosomal CD19 antigen but impair the function of CD19-specific CAR T-cells via TGF-β signaling.
- Published in:
- Frontiers of Medicine, 2024, v. 18, n. 1, p. 128, doi. 10.1007/s11684-023-1010-1
- By:
- Publication type:
- Article
Long-term outcomes with HLX01 (HanliKang<sup>®</sup>), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11876-9
- By:
- Publication type:
- Article
Safety and feasibility of anti-CD19 CAR T cells expressing inducible IL-7 and CCL19 in patients with relapsed or refractory large B-cell lymphoma.
- Published in:
- Cell Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41421-023-00625-0
- By:
- Publication type:
- Article
Outcomes and risk factors of SARS‐CoV‐2 omicron variant in B‐cell lymphoma patients following CD19 targeted CAR‐T therapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 22, p. 20838, doi. 10.1002/cam4.6657
- By:
- Publication type:
- Article
Role of transcription factor FOXM1 in diabetes and its complications (Review).
- Published in:
- International Journal of Molecular Medicine, 2023, v. 52, n. 5, p. 1, doi. 10.3892/ijmm.2023.5304
- By:
- Publication type:
- Article
Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients.
- Published in:
- Frontiers of Medicine, 2023, v. 17, n. 5, p. 889, doi. 10.1007/s11684-023-0994-x
- By:
- Publication type:
- Article
Stacking Ensemble Learning--Based [<sup>18</sup>F]FDG PET Radiomics for Outcome Prediction in Diffuse Large B-Cell Lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1603, doi. 10.2967/jnumed.122.265244
- By:
- Publication type:
- Article
Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 9, p. 646, doi. 10.20892/j.issn.2095-3941.2023.0202
- By:
- Publication type:
- Article
A Decoupled Semantic–Detail Learning Network for Remote Sensing Object Detection in Complex Backgrounds.
- Published in:
- Electronics (2079-9292), 2023, v. 12, n. 14, p. 3201, doi. 10.3390/electronics12143201
- By:
- Publication type:
- Article
Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2022 ASH annual meeting.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00424-z
- By:
- Publication type:
- Article
Integration analysis of tumor metagenome and peripheral immunity data of diffuse large-B cell lymphoma.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1146861
- By:
- Publication type:
- Article
Preclinical evaluation of CD70-specific CAR T cells targeting acute myeloid leukemia.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1093750
- By:
- Publication type:
- Article
Secondary myeloid neoplasms after CD19 CAR T therapy in patients with refractory/relapsed B-cell lymphoma: Case series and review of literature.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1063986
- By:
- Publication type:
- Article
Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-24922-y
- By:
- Publication type:
- Article
Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1015081
- By:
- Publication type:
- Article
Circulating tumor DNA mutation profile is associated with the prognosis and treatment response of Chinese patients with newly diagnosed diffuse large B-cell lymphoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1003957
- By:
- Publication type:
- Article
Case report: Hashimoto's thyroiditis after CD19 chimeric antigen receptor T-cell therapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.995496
- By:
- Publication type:
- Article
Risk of HBV reactivation in relapsed or refractory diffuse large B-cell lymphoma patients receiving Bruton tyrosine kinase inhibitors therapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.982346
- By:
- Publication type:
- Article
Case Report: Primary Cardiac T-Cell Lymphoma With Complete Atrio-Ventricular Block Diagnosed by Endomyocardial Biopsy.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Cover Image, Volume 42, Issue 6.
- Published in:
- Cancer Communications, 2022, v. 42, n. 6, p. i, doi. 10.1002/cac2.12323
- By:
- Publication type:
- Article
Epi‐immunotherapy for cancers: rationales of epi‐drugs in combination with immunotherapy and advances in clinical trials.
- Published in:
- Cancer Communications, 2022, v. 42, n. 6, p. 493, doi. 10.1002/cac2.12313
- By:
- Publication type:
- Article
Neuropilin-1 Identifies a New Subpopulation of TGF-β-Induced Foxp3<sup>+</sup> Regulatory T Cells With Potent Suppressive Function and Enhanced Stability During Inflammation.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.900139
- By:
- Publication type:
- Article
Aberrantly Activated APOBEC3B Is Associated With Mutant p53-Driven Refractory/Relapsed Diffuse Large B-Cell Lymphoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.888250
- By:
- Publication type:
- Article
A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [<sup>18</sup>F]FDG PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 4, p. 1298, doi. 10.1007/s00259-021-05572-0
- By:
- Publication type:
- Article
CD19-targeted BiTE expression by an oncolytic vaccinia virus significantly augments therapeutic efficacy against B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00634-4
- By:
- Publication type:
- Article
A Lightweight YOLOv4-Based Forestry Pest Detection Method Using Coordinate Attention and Feature Fusion.
- Published in:
- Entropy, 2021, v. 23, n. 12, p. 1587, doi. 10.3390/e23121587
- By:
- Publication type:
- Article
Simulation and Optimization Studies of the LHCb Beetle Readout ASIC and Machine Learning Approach for Pulse Shape Reconstruction.
- Published in:
- Sensors (14248220), 2021, v. 21, n. 18, p. 6075, doi. 10.3390/s21186075
- By:
- Publication type:
- Article
Nocardia farcinica Brain Abscess in a Multiple Myeloma Patient Treated with Proteasome Inhibitor: A Case Report and Review of the Literature.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
CD70‐targeting CAR‐T cells have potential activity against CD19‐negative B‐cell Lymphoma.
- Published in:
- Cancer Communications, 2021, v. 41, n. 9, p. 925, doi. 10.1002/cac2.12201
- By:
- Publication type:
- Article
Treatment-Related Adverse Events of Chimeric Antigen Receptor T-Cell (CAR T) in Clinical Trials: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3912, doi. 10.3390/cancers13153912
- By:
- Publication type:
- Article
Risk of HBV Reactivation in Patients With Resolved HBV Infection Receiving Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Without Antiviral Prophylaxis.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.638678
- By:
- Publication type:
- Article
Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.693670
- By:
- Publication type:
- Article
Outcomes in refractory diffuse large B‐cell lymphoma: results from a multicenter real‐world study in China.
- Published in:
- Cancer Communications, 2021, v. 41, n. 3, p. 229, doi. 10.1002/cac2.12126
- By:
- Publication type:
- Article
Persistent Negative Antibody Test in COVID-19 Patient: A Case Report.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma.
- Published in:
- Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40164-020-00188-w
- By:
- Publication type:
- Article
MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8<sup>+</sup> T lymphocytes in human diffuse large B cell lymphoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. N.PAG, doi. 10.1186/s13046-020-01752-2
- By:
- Publication type:
- Article
A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 963, doi. 10.1634/theoncologist.2019-0986
- By:
- Publication type:
- Article
Sustained Remission of Relapsed or Refractory Mantle Cell Lymphoma After 4-1BB-Based CD19-Directed CAR-T Therapy.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 12163, doi. 10.2147/OTT.S280535
- By:
- Publication type:
- Article
Genotyping on ctDNA Identifies Shifts in Mutation Spectrum Between Newly Diagnosed and Relapse/Refractory DLBCL.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 10797, doi. 10.2147/OTT.S275334
- By:
- Publication type:
- Article
Decitabine-Mediated Epigenetic Reprograming Enhances Anti-leukemia Efficacy of CD123-Targeted Chimeric Antigen Receptor T-Cells.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.01787
- By:
- Publication type:
- Article
The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma.
- Published in:
- Signal Transduction & Targeted Therapy, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41392-020-00256-x
- By:
- Publication type:
- Article
SARS-CoV-2 induced thrombocytopenia as an important biomarker significantly correlated with abnormal coagulation function, increased intravascular blood clot risk and mortality in COVID-19 patients.
- Published in:
- Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40164-020-00172-4
- By:
- Publication type:
- Article
Somatic Mutations Confer Severe Peripheral Neuropathy in POEMS Syndrome-Associated Multicentric Castleman Disease.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Long Noncoding RNAs in Diffuse Large B-Cell Lymphoma: Current Advances and Perspectives.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 4295, doi. 10.2147/OTT.S253330
- By:
- Publication type:
- Article